RMFEX
Price
$55.46
Change
+$0.11 (+0.20%)
Updated
May 8 closing price
Net Assets
100.91B
VGRTX
Price
$76.98
Change
+$0.28 (+0.37%)
Updated
May 8 closing price
Net Assets
6.03B
Ad is loading...

RMFEX vs VGRTX

Header iconRMFEX vs VGRTX Comparison
Open Charts RMFEX vs VGRTXBanner chart's image
American Funds American Mutual R4
Price$55.46
Change+$0.11 (+0.20%)
VolumeN/A
Net Assets100.91B
JPMorgan US Value R2
Price$76.98
Change+$0.28 (+0.37%)
VolumeN/A
Net Assets6.03B
RMFEX vs VGRTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFEX vs. VGRTX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and VGRTX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 101B vs. VGRTX (6.03B). RMFEX pays higher dividends than VGRTX: RMFEX (1.65) vs VGRTX (0.96). RMFEX was incepted earlier than VGRTX: RMFEX (23 years) vs VGRTX (10 years). VGRTX (1.25) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. VGRTX (18.00). VGRTX has a lower initial minimum investment than RMFEX: VGRTX (0) vs RMFEX (250). RMFEX annual gain was more profitable for investors over the last year : 5.68 vs. VGRTX (3.52). VGRTX return over 5 years is better than : 81.43 vs. RMFEX (58.56).
RMFEXVGRTXRMFEX / VGRTX
Total Expense Ratio0.621.1952%
Annual Report Gross Expense Ratio0.621.2550%
Fund Existence23 years10 years-
Gain YTD1.374-1.110-124%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets101B6.03B1,674%
Annual Yield % from dividends1.650.96172%
Returns for 1 year5.683.52161%
Returns for 3 years18.3824.9574%
Returns for 5 years58.5681.4372%
Returns for 10 years66.50N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEAPX27.40N/A
N/A
Principal Glb Emerging Markets R3
AHSCX11.33N/A
N/A
Alger Health Sciences C
FAGCX181.98N/A
N/A
Fidelity Advisor Growth Opps I
MLPNX6.11N/A
N/A
Invesco SteelPath MLP Alpha Plus Y
MDRFX20.31N/A
N/A
BlackRock Mid-Cap Value Investor A